Anti-tuberculosis drug bedaquiline suppresses osteoclastogenesis and prevents bone loss by modulating glycolysis and histone lactylation — ASN Events
  1. Schedule
  2. Concurrent Session: Symposium - Beyond mechanics - endocrine and cellular crosstalk between muscle and bone
  3. Anti-tuberculosis drug bedaquiline suppresses osteoclastogenesis and prevents bone loss by modulating glycolysis and histone lactylation

Anti-tuberculosis drug bedaquiline suppresses osteoclastogenesis and prevents bone loss by modulating glycolysis and histone lactylation (#23)

Lizhen Li 1 2 , Xiaohui Cai 1 , Shiyao Wei 1 , Xiaojun Chen 2 , Qian Liu 1 , Kai Chen 2
  1. Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi 530021, Chian
  2. School of Biomedical Sciences, The University of Western Australia, Perth 6009, Western Australia, Australia
Publish consent withheld